Prosecution Insights
Last updated: October 04, 2026

Taipei Medical University

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Transportation, E-Commerce & Mechanical Systems • Medical Devices & Mechanical Engineering

8 pending office actions • 5 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 13 patents granted in the last 365 days

Analysis

Taipei Medical University is currently overseeing 9 pending office actions in the Medical Devices & Mechanical Engineering technology area. These 9 actions are distributed across 9 distinct examiners, indicating a broad range of individual oversight. The portfolio is further spread across 6 distinct art units, which reflects the technical variety in the university's pending applications. This distribution is present across the 9 pending office actions currently on record.

The busiest examiner, BECCIA, CHRISTOPHER J, is handling 1 busiest examiner pending action. Given the number of examiners for the pending office actions, the workload is split so that no individual examiner manages multiple cases. The presence of the actions across 6 distinct art units reflects the prosecution strategy within the Medical Devices & Mechanical Engineering sector. Managing the various examiners requires a flexible approach to address the requirements of the art units.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

8
Total Pending OAs
5
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
1
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (62%)
2
Medium (25%)
1
Easy (12%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (12%)
§101 + other1 (12%)
§103 only2 (25%)
§112 only1 (12%)
Multi-statute (no §101)3 (38%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
25% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
3
Mechanical / Eng
38% of docket
3
Business / Other
38% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BECCIA, CHRISTOPHER J 1 83.5% +14.0%
AUDET, MAURY A 1 50.1% +23.9%
HILSMIER, HEIDI ANN 1 58.3% +61.1%
MOLOYE, TITILAYO 1 62.5% +47.9%
SCHACHERMEYER, SAMANTHA LYNN 1 36.8% +72.6%
GEBREMICHAEL, BRUK A 1 22.1% +23.4%
NEWTON, CHAD A 1 37.6% +23.2%
HERBERT, MADISON TAYLOR 1 59.1% +53.7%

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18326004 METHOD AND APPARATUS FOR PREDICTING PERSISTENT POSTCONCUSSIVE NEUROPSYCHIATRIC SYMPTOMS USING THALAMOCORTICAL COHERENCE NEWTON, CHAD A 75d
18959657 BIOCOMPATIBLE COMPOSITION, METHOD FOR PREPARING THE SAME, AND METHOD FOR TISSUE ADHESION BECCIA, CHRISTOPHER J —
18746300 Pharmaceutical Composition and Method for Treating Neurodegenerative Disorders Utilising the Pharmaceutical Composition MOLOYE, TITILAYO —
18641154 COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING PRECOCIOUS PUBERTY SCHACHERMEYER, SAMANTHA LYNN —
18467722 METHOD, THE COMPUTING DEIVCE, AND THE NON-TRANSITORY COMPUTER-READABLE RECORDING MEDIUM FOR PROVIDING COGNITIVE TRAINING GEBREMICHAEL, BRUK A —

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18765430 SYSTEM AND METHOD FOR MONITORING BLOOD PRESSURE HILSMIER, HEIDI ANN 8d overdue
18326004 METHOD AND APPARATUS FOR PREDICTING PERSISTENT POSTCONCUSSIVE NEUROPSYCHIATRIC SYMPTOMS USING THALAMOCORTICAL COHERENCE NEWTON, CHAD A 75d
18959657 BIOCOMPATIBLE COMPOSITION, METHOD FOR PREPARING THE SAME, AND METHOD FOR TISSUE ADHESION BECCIA, CHRISTOPHER J —
18806827 NOVEL PEPTIDE, USGAES THEREOF AND PHARMACEUTICAL COMPOSITION HAVING THE SAME AUDET, MAURY A —
18746300 Pharmaceutical Composition and Method for Treating Neurodegenerative Disorders Utilising the Pharmaceutical Composition MOLOYE, TITILAYO —
18641154 COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING PRECOCIOUS PUBERTY SCHACHERMEYER, SAMANTHA LYNN —
18467722 METHOD, THE COMPUTING DEIVCE, AND THE NON-TRANSITORY COMPUTER-READABLE RECORDING MEDIUM FOR PROVIDING COGNITIVE TRAINING GEBREMICHAEL, BRUK A —
17935917 PCR DETECTION DEVICE AND SYSTEM HERBERT, MADISON TAYLOR —

Top Art Units

Art UnitApps
3796 1
1615 1
3715 1
3681 1
1758 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18959657 BIOCOMPATIBLE COMPOSITION, METHOD FOR PREPARING THE SAME, AND METHOD FOR TISSUE ADHESION BECCIA, CHRISTOPHER J — §102§103 Non-Final OA — Pending Nov 26, 2024
18806827 NOVEL PEPTIDE, USGAES THEREOF AND PHARMACEUTICAL COMPOSITION HAVING THE SAME AUDET, MAURY A — §112 Non-Final OA — Pending Aug 16, 2024
18765430 SYSTEM AND METHOD FOR MONITORING BLOOD PRESSURE HILSMIER, HEIDI ANN 3796 §103 Final Rejection 8d overdue Pending Jul 08, 2024
18746300 Pharmaceutical Composition and Method for Treating Neurodegenerative Disorders Utilising the Pharmaceutical Composition MOLOYE, TITILAYO 1615 §102§103 Non-Final OA — Pending Jun 18, 2024
18641154 COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING PRECOCIOUS PUBERTY SCHACHERMEYER, SAMANTHA LYNN — §103§112 Non-Final OA — Pending Apr 19, 2024
18467722 METHOD, THE COMPUTING DEIVCE, AND THE NON-TRANSITORY COMPUTER-READABLE RECORDING MEDIUM FOR PROVIDING COGNITIVE TRAINING GEBREMICHAEL, BRUK A 3715 §101§103§112 Final Rejection — Pending Sep 14, 2023
18326004 METHOD AND APPARATUS FOR PREDICTING PERSISTENT POSTCONCUSSIVE NEUROPSYCHIATRIC SYMPTOMS USING THALAMOCORTICAL COHERENCE NEWTON, CHAD A 3681 §101 Final Rejection 75d Pending May 31, 2023
17935917 PCR DETECTION DEVICE AND SYSTEM HERBERT, MADISON TAYLOR 1758 §103 Non-Final OA — Pending Sep 27, 2022

Managing Taipei Medical University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month